Does Medicare cover medical cannabis?

No. Medicare Part D does not cover medical cannabis in any form, and neither does Medicaid or standard private insurance. Cannabis remains a federally controlled substance, and Medicare can only cover FDA-approved medications. Even if rescheduling from Schedule I to Schedule III is completed under the December 2025 executive order, coverage would still require FDA approval of specific cannabis products — a process that typically takes years of clinical trials.

Are any cannabis-related medications covered by Medicare?

Yes, two FDA-approved cannabinoid medications are covered. Dronabinol (brand names Marinol and Syndros), a synthetic THC approved for chemotherapy-related nausea and AIDS-related anorexia, is typically placed on Tier 4 of Part D formularies with prior authorization and step therapy requirements. Epidiolex, a pharmaceutical-grade CBD approved for seizures in Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex, falls within Part D's protected anticonvulsant class.

Can I deduct medical cannabis costs on my taxes?

No. IRS Publication 502 explicitly excludes controlled substances that are not legal under federal law from the medical expense deduction. This means medical cannabis cannot be deducted, and FSA or HSA funds cannot be used to purchase it. However, FDA-approved cannabinoid medications such as dronabinol and Epidiolex can be paid for with FSA/HSA funds and may qualify as deductible medical expenses.

How much does medical cannabis cost out of pocket for seniors?

A 2024 Memorial Sloan Kettering study of 248 cancer patients published in JNCI Monographs found a median monthly cost of $80, with an interquartile range of $25 to $150. However, costs vary widely and can reach $500 per month depending on dosage, product type, and state. Additional costs include medical card fees ($25 to $200 per year) and physician certification visits ($85 to $300).

Medicare Will Not Pay for Cannabis — What Is Covered

Federal prohibition keeps cannabis off Medicare, Medicaid, and private insurance. Dronabinol and Epidiolex are covered. State assistance options and FSA/HSA reality.

The Short Answer: No Coverage

Medicare does not cover medical cannabis. Neither does Medicaid. Neither does standard private insurance. This is the single most important financial fact for seniors considering cannabis, and it is unlikely to change soon.

The reason is straightforward: Medicare Part D can only cover FDA-approved medications. Cannabis — including state-legal medical cannabis — has no FDA approval as a drug product. Until specific cannabis formulations go through FDA clinical trials, receive approval, and are assigned an NDC (National Drug Code), Medicare cannot list them on any formulary. Strong evidence

Will Rescheduling Change This?

In December 2025, President Trump signed an executive order directing the rescheduling of cannabis from Schedule I to Schedule III. This is significant — it would remove the 280E tax burden from cannabis businesses and open new research pathways. But it will not automatically trigger insurance coverage.

Schedule III includes drugs like ketamine, anabolic steroids, and testosterone — all of which require FDA approval of specific products before insurance covers them. Rescheduling changes how cannabis is regulated, not whether individual products have been proven safe and effective to FDA standards. That approval process typically takes years of clinical trials.

The CMS Pilot Program

Alongside the executive order, CMS Administrator Dr. Mehmet Oz announced a limited Innovation Center pilot program that would allow Medicare beneficiaries to receive up to $500 annually in hemp-derived CBD products when recommended by a physician. However, a lawsuit challenging the program was filed on April 1, 2026, and its legal status remains uncertain. Do not count on this benefit being available.

What Medicare Does Cover: Two FDA-Approved Cannabinoid Medications

Two prescription cannabinoid medications have FDA approval and are covered by Medicare Part D:

Dronabinol (Marinol / Syndros)

Synthetic THC approved for chemotherapy-related nausea and AIDS-related anorexia. Typically placed on Tier 4 of Part D formularies, which means higher copays plus prior authorization and step therapy requirements — your doctor must document that you tried other treatments first. Through discount services, out-of-pocket cost runs approximately $70/month.

Epidiolex

Pharmaceutical-grade CBD approved for seizures in Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. Because it treats epilepsy, it falls within Part D's protected anticonvulsant class, which means plans must cover it. This drug is relevant to a small subset of seniors, but it demonstrates that FDA-approved cannabinoids can and do get covered.

What Medical Cannabis Actually Costs

Without insurance, you are paying the full price. Here is what the research shows. Moderate evidence

A 2024 Memorial Sloan Kettering study of 248 cancer patients (published in JNCI Monographs) found:

Median monthly cost: $80
Interquartile range: $25 to $150
Some patients spent up to $500/month depending on dosage and product type

On top of product costs, expect these recurring expenses:

Medical card fees: $25 to $200/year depending on your state
Physician certification visits: $85 to $300 (some states require annual recertification)

For detailed strategies to reduce these costs, see Cost & Discount Strategies.

Tax Deductions, FSA, and HSA

Medical cannabis is not tax-deductible. IRS Publication 502 explicitly excludes controlled substances that are not legal under federal law from the medical expense deduction. This applies regardless of whether your state has legalized medical cannabis.

FSA and HSA funds cannot be used to purchase cannabis products. However, they can be used for FDA-approved cannabinoid medications (dronabinol and Epidiolex), and the physician visit for your cannabis certification may qualify as a deductible medical expense — consult your tax preparer.

State Financial Assistance Programs

Several states have created programs specifically to reduce cannabis costs for low-income patients and seniors:

Pennsylvania

The Medical Marijuana Assistance Program waives card fees for patients on Medicaid, SNAP, or WIC. A Phase 3 pilot for PACE/PACENET participants (Pennsylvania's senior prescription assistance programs) offers a $50/month credit toward medical cannabis purchases.

Oregon

Reduces the medical card fee to $20 for SSI recipients and veterans, compared to the standard $200.

Massachusetts

Waives the $50 registration fee for MassHealth enrollees and patients below 300% of the federal poverty level.

California (Berkeley)

Requires licensed dispensaries to donate 2% of annual supply by weight free of charge to verified very-low-income patients.

Dispensary Senior Discounts

Most dispensaries in legal states offer standing senior discounts, typically 10% to 25% off for patients 55, 60, or 65 and older. These are not advertised loudly — you usually need to ask. Many dispensaries also run daily or weekly deals, loyalty programs, and first-time patient discounts that can stack with senior pricing.

Always ask at the register. Bring your ID. The savings add up over months of regular purchases. For a full breakdown, see Cost & Discount Strategies.

Cost & Discount Strategies — How to reduce out-of-pocket cannabis expenses
Getting Your Medical Card — State-by-state process, fees, and requirements
Find a Cannabis-Friendly Doctor — Physician directories and what to expect at your visit